• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• S
• Sadayappan, Sakthivel
  University of Cincinnati College of Medicine
• (M1030-01-07) E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
  Sakthivel Sadayappan
  Favorite
• Salha, Danielle
  Altasciences
• (T1130-01-07) Current Strategies for Using Commercial Kit in Regulated Bioanalysis
  Danielle Salha
  Favorite
• Schiller, James
  Merck & Co., Inc.
• (M1130-01-07) Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
  James Schiller
  Favorite
• Schindele, Patrick
  Agilent Technologies Deutschland GmbH
• (T1430-01-07) Importance of Quality Control of In Vitro Transcribed RNA
  Patrick Schindele
  Favorite
• Schwemler, Timothy
  Alliance Pharma Inc.
• (M1030-01-08) Quantitation of Diazepam and Its Metabolites Using High-Throughput Rapidfire Mass Spectrometry
  Timothy Schwemler
  Favorite
• Serafini, Sergio
  Novartis Institutes for BioMedical Research
• (T1030-01-05) Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
  Sergio Serafini
  Favorite
• Seshadri, Soorya
  EpiVax Inc.
• (M1130-01-05) Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
  Soorya Seshadri
  Favorite
• Shaghaghi, Hoora
  Alliance Pharma Inc.
• (M1030-01-08) Quantitation of Diazepam and Its Metabolites Using High-Throughput Rapidfire Mass Spectrometry
  Hoora Shaghaghi
  Favorite
• Sharkey, James
  Gyros Protein Technologies
• (M1030-01-01) Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
  James Sharkey
  Favorite
• (M1330-01-01) Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
  James Sharkey
  Favorite
• (T1030-01-01) Selectivity of Human Cytokine Quantification in Human and Cyno Serum Using a Fully Automated Microfluidic Immunoassay System
  James Sharkey
  Favorite
• (T1130-01-01) Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
  James Sharkey
  Favorite
• Shaw, Pang Chui
  Chinese University of Hong Kong
• (T1130-01-09) Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
  Pang Chui Shaw
  Favorite
• Shen, Christina
  Amgen Inc.
• (M1330-01-04) High-Throughput and Selective LC-MS Quantitation of SMARCA2/4 for SMARCA2 Targeted Protein Degrader Cross-Species Pharmacodynamics Analysis
  Christina Shen
  Favorite
• Shiner, Steve
  Waters Corporation
• (T1030-01-02) Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
  Steve Shiner
  Favorite
• Shyr, Zeenat
  National Center for Advancing Translational Sciences
• (T1030-01-07) Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
  Zeenat Shyr
  Favorite
• Siddiqui, Nabil
  Memorial Sloan Kettering Cancer Center
• (M1030-01-07) E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
  Nabil Siddiqui
  Favorite
• Singh, Jagdish
  North Dakota State University
• (M1430-01-04) Brain-Targeted Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA to Manage Neurogenic Hypertension
  Jagdish Singh
  Favorite
• Sodhi, Chhinder
  Johns Hopkins University
• (T1330-01-01) ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
  Chhinder Sodhi
  Favorite
• Somaida, Ahmed
  Philipps University of Marburg
• (T1430-01-08) Sensitization of Paclitaxel-Induced Apoptosis by Echinops giganteus Extract via Downregulation of PI3K/Akt/NF-κB Pathway and Enrichment of TIMP-3 in Cervical Cancer
  Ahmed Somaida
  Favorite
• Song, Qianbo
  Chinese University of Hong Kong
• (T1130-01-09) Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
  Qianbo Song
  Favorite
• Souaysene, Amanda
  KCAS Bioanalytical & Biomarker
• (T1030-01-06) Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
  Amanda Souaysene
  Favorite
• Spires, Jessica
  Simulations Plus, Inc.
• (T1330-01-06) Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
  Jessica Spires
  Favorite
• Srinivasan, Aruna
  Syngene International Ltd.
• (T1430-01-09) An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
  Aruna Srinivasan
  Favorite
• Steffen, Ann-Charlott
  Gyros Protein Technologies
• (T1030-01-01) Selectivity of Human Cytokine Quantification in Human and Cyno Serum Using a Fully Automated Microfluidic Immunoassay System
  Ann-Charlott Steffen
  Favorite
• Stephens, Patricia
  Labcorp
• (T1030-01-05) Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
  Patricia Stephens
  Favorite
• Strauch, Bettina
  Agilent Technologies Deutschland GmbH
• (T1430-01-07) Importance of Quality Control of In Vitro Transcribed RNA
  Bettina Strauch
  Favorite
• Subramani, Thangamma
  Syngene International Ltd.
• (M1430-01-08) Antibody Titration: Titer Cut-Point or Screening Cut-Point: Which One Is a Practical Option?
  Thangamma Subramani
  Favorite
• (T1430-01-09) An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
  Thangamma Subramani
  Favorite
• Sun, Chengwen
  North Dakota State University
• (M1430-01-04) Brain-Targeted Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA to Manage Neurogenic Hypertension
  Chengwen Sun
  Favorite
• Sun, Wei
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Wei Sun
  Favorite